From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

DYSPLASTIC NEVI: RISK FACTOR FOR MELANOMA.

Dysplastic nevi have been associated with melanoma risk in some epidemiologic studies, but the data are far from convincing. This case-control study compared number and type of nevi in 716 patients who had newly diagnosed melanoma with 1,014 control subjects of the same age, sex, race, and geographic distribution.

Nevi were considered dysplastic if they were at least 5 mm in size and entirely flat. At least two of the following features were also necessary: variable pigmentation; an irregular, asymmetric outline; and indistinct borders.

Melanoma was strongly associated with number, size, and dysplastic nature of nevi. Patients with 100 or more small nevi (2 to 5 mm) had an adjusted relative risk for melanoma of 3.1 compared with patients with 0 to 24. Nondysplastic nevi greater than 5 mm were also associated with melanoma, with an adjusted relative risk of 2.3 in subjects with 10 or more nevi compared with those with none. Dysplastic nevi, however, represented the most potent risk factor, with an adjusted relative risk of 2.2 if just one was present, and of 12 if there were 10 or more.

Comment: These data demonstrate a modest increase in melanoma risk for patients with small nondysplastic nevi, and a major increase for those with dysplastic lesions.

— TH Lee

Published in Journal Watch General Medicine May 16, 1997

Citation(s):

Tucker MA et al. Clinically recognized dysplastic nevi: A central risk factor for cutaneous melanoma. JAMA 1997 May 14 277 1439-1444.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1997. Massachusetts Medical Society. All rights reserved.